Gastroesophageal Cancer
📧 Sign up to get email alerts when something new happens for Gastroesophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma [Phase 1]
Phase 1 trial updating TAS-102 combined with irinotecan in second-line or higher gastric and gastroesophageal adenocarcinoma; study complete…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial assessing SHR-1210 in combination with capecitabine plus oxaliplatin or apatinib for advanced gastric cancer has comp…
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors [Phase 1, Phase 2]
Results from a Phase 1/2 study of INCB001158 in combination with chemotherapy for solid tumors, including biliary tract cancer and colorecta…
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy [Phase 3]
Phase 3 trial evaluating early palliative care in patients with metastatic upper gastrointestinal cancers treated with first-line chemothera…
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer [Phase 1]
Phase 1 study investigating bemarituzumab (FPA144) with modified FOLFOX6 in gastric/gastroesophageal cancer has completed with results poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer [Phase 2]
Phase 2 trial updating nab-paclitaxel plus ramucirumab as second-line treatment for metastatic gastroesophageal cancer completed with posted…
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma [Phase 2]
Phase 2 trial evaluating ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in HER2-positive gastroesophageal adenocarcinoma…
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy [Phase 2]
Phase 2 study update for KH903 in advanced gastric or gastroesophageal junction adenocarcinoma as second-line therapy; status not disclosed.
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma [Phase 2]
Phase 2 proof-of-concept trial evaluating ibrutinib in c-MYC and HER2 amplified oesophagogastric carcinoma (gastroesophageal cancer).
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression [Phase 1]
Phase 1 study of ADCT-502 in HER2-expressing advanced solid tumors including breast cancer and non-small cell lung cancer has terminated wit…
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors [Phase 2]
Phase 2 clinical trial update of durvalumab (MEDI4736) in patients with brain metastases from epithelial-derived tumors, with terminated sta…
-
CLINICAL_TRIALS withdrawal · 2017-03-14Clinical Trial Update: Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment [Phase 2]
A Phase 2 trial evaluating Afatinib in combination with weekly Paclitaxel as second-line therapy for HER-2 positive gastric and gastroesopha…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Esophageal Stump Washout [NA]
The esophageal stump washout trial sponsored by Kantonsspital Liestal has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Therapeutic Individualization for Patients With Locally Advanced Gastric and Gastroesophageal Cancer
This update reports on a completed clinical trial investigating therapeutic individualization for patients with locally advanced gastric and…
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT [Phase 3]
Phase 3 trial comparing low molecular weight heparin plus chemotherapy versus chemotherapy alone in inoperable gastric and gastroesophageal …
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating oxaliplatin-based chemotherapy with chemoradiotherapy for esophageal and gastroesophageal cancers; …
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer [Phase 2]
Phase 2 trial evaluating FOLFOX with Bevacizumab for metastatic or unresectable gastroesophageal and gastric cancer; results were posted in …
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen [Phase 2]
Phase 2 trial update for chemotherapy in gastroesophageal cancers that progressed after one prior regimen; study terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer [Phase 2]
Phase II randomized trial comparing EOX (epirubicin, oxaliplatin, capecitabine) versus ElTax (docetaxel, oxaliplatin) in advanced gastroesop…